282 related articles for article (PubMed ID: 6239713)
1. Synthesis of 4-methylumbelliferyl-beta-D-N-acetylglucosamine-6-sulfate and its use in classification of GM2 gangliosidosis genotypes.
Bayleran J; Hechtman P; Saray W
Clin Chim Acta; 1984 Nov; 143(2):73-89. PubMed ID: 6239713
[TBL] [Abstract][Full Text] [Related]
2. Tay-Sachs disease with hexosaminidase A: characterization of the defective enzyme in two patients.
Bayleran J; Hechtman P; Kolodny E; Kaback M
Am J Hum Genet; 1987 Oct; 41(4):532-48. PubMed ID: 2959149
[TBL] [Abstract][Full Text] [Related]
3. Detection of Tay-Sachs disease carriers among individuals with thermolabile hexosaminidase B.
Peleg L; Goldman B
Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):65-9. PubMed ID: 8003579
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of 4-methylumbelliferyl-6-sulfo-2-acetamido-2-deoxy-beta-D-glucopyrano sid e for the diagnosis of GM2 gangliosidoses in leukocytes.
Inui K; Wenger DA
Clin Genet; 1984 Oct; 26(4):318-21. PubMed ID: 6238730
[TBL] [Abstract][Full Text] [Related]
5. A new form of residual hexosaminidase activity in infantile Tay Sachs disease fibroblasts.
Hechtman P; Khoo K; Isaacs C
Clin Genet; 1983 Sep; 24(3):206-15. PubMed ID: 6226462
[TBL] [Abstract][Full Text] [Related]
6. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
7. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
8. Identification of GM2-gangliosidosis B1 variant carriers.
Ribeiro MG; Pinto R; Oliveira P; Sá Miranda MC
J Inherit Metab Dis; 1993; 16(6):1003-11. PubMed ID: 8127050
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis of GM2 gangliosidosis with high residual hexosaminidase A activity (variant B1; pseudo AB variant).
Conzelmann E; Nehrkorn H; Kytzia HJ; Sandhoff K; Macek M; Lehovský M; Elleder M; Jirásek A; Kobilková J
Pediatr Res; 1985 Nov; 19(11):1220-4. PubMed ID: 2933632
[TBL] [Abstract][Full Text] [Related]
10. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
[TBL] [Abstract][Full Text] [Related]
11. Molecular forms of beta-N-acetylhexosaminidase in Epstein-Barr virus-transformed lymphoid cell lines from normal subjects and patients with Tay-Sachs disease.
Salvayre R; Maret A; Negre A; Lenoir G; Vuillaume M; Icart J; Didier J; Douste-Blazy L
Eur J Biochem; 1983 Jul; 133(3):627-33. PubMed ID: 6305653
[TBL] [Abstract][Full Text] [Related]
12. Variant of GM2-gangliosidosis with hexosaminidase A having a severely changed substrate specificity.
Kytzia HJ; Hinrichs U; Maire I; Suzuki K; Sandhoff K
EMBO J; 1983; 2(7):1201-5. PubMed ID: 6226523
[TBL] [Abstract][Full Text] [Related]
13. Juvenile GM2 gangliosidosis (AMB variant): inability to activate hexosaminidase A by activator protein.
Inui K; Grebner EE; Jackson LG; Wenger DA
Am J Hum Genet; 1983 Jul; 35(4):551-64. PubMed ID: 6224417
[TBL] [Abstract][Full Text] [Related]
14. Hereditary heat-labile hexosaminidase B: its implication for recognizing Tay-Sachs genotypes.
Navon R; Nutman J; Kopel R; Gaber L; Gadoth N; Goldman B; Nitzan M
Am J Hum Genet; 1981 Nov; 33(6):907-15. PubMed ID: 6459736
[TBL] [Abstract][Full Text] [Related]
15. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
Conzelmann E; Sandhoff K
Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
[TBL] [Abstract][Full Text] [Related]
16. Identification of candidate active site residues in lysosomal beta-hexosaminidase A.
Fernandes MJ; Yew S; Leclerc D; Henrissat B; Vorgias CE; Gravel RA; Hechtman P; Kaplan F
J Biol Chem; 1997 Jan; 272(2):814-20. PubMed ID: 8995368
[TBL] [Abstract][Full Text] [Related]
17. Crystallographic structure of human beta-hexosaminidase A: interpretation of Tay-Sachs mutations and loss of GM2 ganglioside hydrolysis.
Lemieux MJ; Mark BL; Cherney MM; Withers SG; Mahuran DJ; James MN
J Mol Biol; 2006 Jun; 359(4):913-29. PubMed ID: 16698036
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and carrier detection of Tay-Sachs disease: direct determination of hexosaminidase A using 4-methylumbelliferyl derivatives of beta-N-acetylglucosamine-6-sulfate and beta-N-acetylgalactosamine-6-sulfate.
Ben-Yoseph Y; Reid JE; Shapiro B; Nadler HL
Am J Hum Genet; 1985 Jul; 37(4):733-40. PubMed ID: 9556661
[TBL] [Abstract][Full Text] [Related]
19. Thermodynamic characterisation of the mutated isoenzyme A of beta-N-acetylhexosaminidase in GM2-gangliosidosis B1 variant.
Pérez LF; Ribeiro HM; Casal JA; Pinto RA; Sá Miranda MC; Tutor JC
Clin Chim Acta; 1999 Jul; 285(1-2):45-51. PubMed ID: 10481922
[TBL] [Abstract][Full Text] [Related]
20. Tay-Sachs disease heterozygote detection: use of a centrifugal analyser for automation of hexosaminidase assays with two different artificial substrates.
Landels EC; Ellis IH; Bobrow M; Fensom AH
J Med Genet; 1991 Feb; 28(2):101-9. PubMed ID: 1825851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]